In nasopharyngeal carcinoma, EMP2 expression is generally weak or absent in tumor tissues but moderate to strong in adjacent non-tumor tissues, with higher levels of EMP2 associated with significantly longer survival times. This evidence concerns the gene EMP2 and neoplasm.